<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Product</title>
<description>International Business News - Product</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Ahead of the Bell: Paper, forest products makers</title>
  <description>Shares of forest and paper products companies could see active trading Friday after an analyst cut his price targets on shares of many of those companies to reflect dimming prospects from a "deepening recession."</description>
    <link>http://www.ibtimes.com/articles/20081010/ahead-of-the-bell-paper-forest-products-makers.htm</link> 
  <pubDate>Fri, 10 Oct 2008 08:31:14 EDT</pubDate>
  </item>


  <item>
  <title>Genentech reports brain disease in Raptiva patient</title>
  <description>Genentech Inc. said late Thursday it has informed physicians that its psoriasis drug Raptiva may have contributed to the development of a rare brain disease in one patient, while another taking the drug developed neurologic symptoms and died of unknown causes.</description>
    <link>http://www.ibtimes.com/articles/20081003/genentech-reports-brain-disease-in-raptiva-patient.htm</link> 
  <pubDate>Fri, 03 Oct 2008 08:03:52 EDT</pubDate>
  </item>


  <item>
  <title>PPD completes InnoPharm buyout</title>
  <description>Contract research company Pharmaceutical Product Development Inc. said late Wednesday it completed the buyout of Russian drug development services company InnoPharm Ltd.</description>
    <link>http://www.ibtimes.com/articles/20081002/ppd-completes-innopharm-buyout.htm</link> 
  <pubDate>Thu, 02 Oct 2008 10:15:12 EDT</pubDate>
  </item>


  <item>
  <title>Cyberonics mulls options in VNS partner search</title>
  <description>Medical device maker Cyberonics Inc. said Wednesday it still has not found a partner for its depression system and reaffirmed its position that it will not conduct additional studies until it has found a collaborator.</description>
    <link>http://www.ibtimes.com/articles/20081001/cyberonics-mulls-options-in-vns-partner-search.htm</link> 
  <pubDate>Wed, 01 Oct 2008 10:39:58 EDT</pubDate>
  </item>


  <item>
  <title>Eurand expects delay in lead drug application</title>
  <description>Drug developer Eurand NV said Tuesday it expects the Food and Drug Administration to take an additional quarter to make a decision on its lead drug candidate because of a raw materials supplier's timeline.</description>
    <link>http://www.ibtimes.com/articles/20080930/eurand-expects-delay-in-lead-drug-application.htm</link> 
  <pubDate>Tue, 30 Sep 2008 10:40:08 EDT</pubDate>
  </item>


  <item>
  <title>Savient still reviewing business options for drug</title>
  <description>Savient Pharmaceuticals Inc. said Friday it is still reviewing business development options for its lead drug candidate Puricase, and said it plans on asking regulators to approve the prospective gout treatment by the end of October.</description>
    <link>http://www.ibtimes.com/articles/20080926/savient-still-reviewing-business-options-for-drug.htm</link> 
  <pubDate>Fri, 26 Sep 2008 08:34:35 EDT</pubDate>
  </item>


  <item>
  <title>CPSC: China milk crisis sign more checks needed</title>
  <description>The recent troubles with contaminated milk in China highlight the need for better enforcement of product safety standards at all stages of manufacturing, U.S. and European consumer safety officials said Wednesday.</description>
    <link>http://www.ibtimes.com/articles/20080924/cpsc-china-milk-crisis-sign-more-checks-needed.htm</link> 
  <pubDate>Wed, 24 Sep 2008 06:05:46 EDT</pubDate>
  </item>


  <item>
  <title>Pfizer takes more time with antibiotic application</title>
  <description>Pfizer Inc. said Tuesday it will withdraw approval requests for the antibiotic dalbavancin and conduct another late-stage clinical trial before reapplying.</description>
    <link>http://www.ibtimes.com/articles/20080909/pfizer-takes-more-time-with-antibiotic-application.htm</link> 
  <pubDate>Tue, 09 Sep 2008 12:40:51 EDT</pubDate>
  </item>


  <item>
  <title>TiVo offers new digital video recorder</title>
  <description>TiVo Inc. said on Thursday it has released a TiVo HD XL Digital Video Recorder, which offers more recording capacity than any other DVR available. The box has 150 hours of high definition television recording capacity along with broadband features available in other DVRs. It will also include broadband features, such as the ability to download movies and TV shows directly to the television and, available on other DVRs.</description>
    <link>http://www.ibtimes.com/articles/20080904/tivo-offers-new-digital-video-recorder.htm</link> 
  <pubDate>Thu, 04 Sep 2008 10:01:35 EDT</pubDate>
  </item>


  <item>
  <title>Sears to launch Army-inspired collection</title>
  <description>Sears Holdings Corp. said Tuesday it will launch a sportswear collection inspired by the First Infantry Division of the U.S. Army. It is the first time the U.S. Army has licensed the use of its marks and insignias.</description>
    <link>http://www.ibtimes.com/articles/20080902/sears-to-launch-army-inspired-collection.htm</link> 
  <pubDate>Tue, 02 Sep 2008 14:22:56 EDT</pubDate>
  </item>


  <item>
  <title>Affymax ends part of Hematide development program</title>
  <description>Affymax Inc. and Japanese partner Takeda Pharmaceutical Co. said Thursday they will cut part of their development program for the anemia drug candidate Hematide and continue focusing on its possible use in kidney disease patients.</description>
    <link>http://www.ibtimes.com/articles/20080828/affymax-ends-part-of-hematide-development-program.htm</link> 
  <pubDate>Thu, 28 Aug 2008 16:23:49 EDT</pubDate>
  </item>


  <item>
  <title>Hi-Tech files for decision on drug exclusivity</title>
  <description>Generic drug developer and nutritional products company Hi-Tech Pharmacal Co. said Thursday it asked a district court to rule that it is eligible for 180 days of market exclusivity for a generic version of Merck's glaucoma treatment Cosopt.</description>
    <link>http://www.ibtimes.com/articles/20080828/hi-tech-files-for-decision-on-drug-exclusivity.htm</link> 
  <pubDate>Thu, 28 Aug 2008 12:57:02 EDT</pubDate>
  </item>


  <item>
  <title>St. Jude says Japan approves Durata lead</title>
  <description>Medical device maker St. Jude Medical Inc. said Wednesday that Japanese regulators have approved its Durata defibrillation lead for sale. Leads are wires that connect implantable heart devices to the heart of a patient, allowing them to deliver shocks that can restore a normal heart rhythm. The Durata was approved by the Japanese Ministry of Health, Labour and Welfare on Wednesday. It received U.S. and European approval in January.</description>
    <link>http://www.ibtimes.com/articles/20080806/st-jude-says-japan-approves-durata-lead.htm</link> 
  <pubDate>Wed, 06 Aug 2008 08:54:36 EDT</pubDate>
  </item>


  <item>
  <title>Lawmakers agree on consumer product safety act</title>
  <description>House and Senate lawmakers reached agreement Monday on legislation to ensure that children's toys are not contaminated with lead and phthalates, require mandatory testing of children's products and increase funding for the Consumer Product Safety Commission.</description>
    <link>http://www.ibtimes.com/articles/20080728/lawmakers-agree-on-consumer-product-safety-act.htm</link> 
  <pubDate>Mon, 28 Jul 2008 18:27:17 EDT</pubDate>
  </item>


  <item>
  <title>Nine West pairs with New Balance for shoe line</title>
  <description>Nine West Group, a division of Jones Apparel Group Inc., said Monday it will create a footwear collection with privately held shoe and apparel maker New Balance.</description>
    <link>http://www.ibtimes.com/articles/20080728/nine-west-pairs-with-new-balance-for-shoe-line.htm</link> 
  <pubDate>Mon, 28 Jul 2008 11:16:18 EDT</pubDate>
  </item>


  <item>
  <title>Onyx gets Chinese approval for liver cancer drug</title>
  <description>Partners Onyx Pharmaceuticals and Bayer said Monday China's drug regulatory agency approved the liver cancer treatment Nexavar, opening the door to one of the largest markets for the drug.</description>
    <link>http://www.ibtimes.com/articles/20080728/onyx-gets-chinese-approval-for-liver-cancer-drug.htm</link> 
  <pubDate>Mon, 28 Jul 2008 11:00:09 EDT</pubDate>
  </item>


  <item>
  <title>Caraustar stops making product at paperboard mill</title>
  <description>Caraustar Industries Inc., which makes converted recycled paperboard, said Tuesday it permanently ceased production of uncoated recycled boxboard at its paperboard mill in Chattanooga, Ga., a move that affected 67 salaried and hourly employees.</description>
    <link>http://www.ibtimes.com/articles/20080722/caraustar-stops-making-product-at-paperboard-mill.htm</link> 
  <pubDate>Tue, 22 Jul 2008 14:01:45 EDT</pubDate>
  </item>


  <item>
  <title>Novartis unit recalling prescription eye drops</title>
  <description>Canada's national public health department on Friday warned consumers not to use a certain type of generic prescription eye drop made by Novartis AG's Sandoz unit because of a heightened safety risk.</description>
    <link>http://www.ibtimes.com/articles/20080718/novartis-unit-recalling-prescription-eye-drops.htm</link> 
  <pubDate>Fri, 18 Jul 2008 17:27:39 EDT</pubDate>
  </item>


  <item>
  <title>Celera gets FDA approval for diagnostic software</title>
  <description>Molecular diagnostics company Celera Corp. said Friday the Food and Drug Administration approved new system software used for HIV monitoring and treatment.</description>
    <link>http://www.ibtimes.com/articles/20080718/celera-gets-fda-approval-for-diagnostic-software.htm</link> 
  <pubDate>Fri, 18 Jul 2008 09:35:25 EDT</pubDate>
  </item>


  <item>
  <title>Whole Foods Market increases seafood standards</title>
  <description>Whole Foods Market Inc. said Wednesday it has boosted standards for farmed seafood sold at its organic foods supermarkets. Whole Foods already prohibits the use of antibiotics, certain preservatives and added growth hormones, but among its new enhanced standards is a requirement by producers to provide detailed information on farming practices.</description>
    <link>http://www.ibtimes.com/articles/20080716/whole-foods-market-increases-seafood-standards.htm</link> 
  <pubDate>Wed, 16 Jul 2008 12:31:50 EDT</pubDate>
  </item>


</channel>
</rss>